Results 101 to 110 of about 1,518 (174)

Optic Atrophy in a Patient With Atypical Pantothenate Kinase-Associated Neurodegeneration.

open access: yes, 2017
Pantothenate kinase-associated neurodegeneration (PKAN) is an autosomal recessive neurodegeneration with brain iron accumulation and characterized by extrapyramidal signs, vision loss, and intellectual decline.
한진우, 한승한, 김도욱
core   +1 more source

Pallidal stimulation improves pantothenate kinase-associated neurodegeneration

open access: yes, 2005
Pantothenate kinase-associated neurodegeneration (PKAN) causes a progressive generalized dystonia which remains pharmacologically intractable. We performed bilateral internal globus pallidus stimulation in six patients with genetically confirmed PKAN who
Annalisa DiGiorgio   +23 more
core   +1 more source

Impaired drug-induced endovesiculation in erythrocytes of patients with acanthocytosis.

open access: yes, 2013
Erythrocytes from patients (ChAc, PKAN+, PKAN-) and control donors were subjected to drug-induced endovesiculation using 3 mM primaquine. The amount of FITC-dextran positive cells (in %) was assessed by flow cytometry as described.
Holger Prokisch (26590)   +14 more
core   +1 more source

The role of impaired De novo Coenzyne A biosynthesis in pantothenate kinase-associated neurodegeneration : insight from a Drosophila model [PDF]

open access: yes, 2010
Pantothenate kinase-associated neurodegeneration (PKAN, OMIM 234200) is an autosomal recessive, progressive neurodegenerative disorder. PKAN is caused by mutations in pantothenate kinase 2 (PANK2), the gene that encodes an enzyme (PANK2) which is a rate ...
Rana, Anil,, Rana, Anil
core  

Phenotypes and Genotypes of Patients with Pantothenate Kinase-Associated Neurodegeneration in Asian and Caucasian Populations: 2 Cases and Literature Review [PDF]

open access: yes, 2020
Objectives. Pantothenate kinase-associated neurodegeneration (PKAN) is a rare disease caused by pantothenate kinase 2 (PANK2, OMIM 606157) mutations. This study is aimed to investigate clinical presentations, pathologies, and genetics in patients with ...
Chia-Ling Huang   +8 more
core  

Advances in inherited and clinical research of pantothenate kinase⁃associated neurodegeneration

open access: yesChinese Journal of Contemporary Neurology and Neurosurgery, 2012
Pantothenate kinase ⁃ associated neurodegeneration (PKAN) is a major form of neurodegeneration with brain iron accumulation or NBIA (formerly called Hallervorden ⁃ Spatz syndrome).
Xiao⁃yuan LI, Xian⁃wen CHEN
doaj  

Case Report: clinical manifestations and imaging features associated with PANK2 c.940C>T variant in PKAN with symmetric basal ganglia calcification

open access: yesFrontiers in Genetics
BackgroundPantothenate kinase-associated neurodegeneration (PKAN) is the most common subtype of neurodegeneration with brain iron accumulation and is classically associated with pallidal iron deposition and the “eye-of-the-tiger” sign on MRI.
Feng Liang   +10 more
doaj   +1 more source

A Case of Retinal Pigmentary Degeneration in PKAN

open access: yesJournal of the Korean Ophthalmological Society, 2013
Seong Ho Jo   +3 more
openaire   +1 more source

Overexpression of human mutant PANK2 mRNAs in zebrafish embryos to gain insight about PKAN pathogenesis

open access: yes, 2017
Pantothenate Kinase Associated Neurodegeneration (PKAN) is an autosomal recessive disorder with mutations in the pantothenate kinase 2 gene (PANK2), encoding an essential enzyme for Coenzyme A (CoA) biosynthesis.
ZIZIOLI, DANIELA   +5 more
core  

Knock-down of pank2 in zebrafish and overexpression of human PANK2 in zebrafish: insight for PKAN pathogenesis

open access: yes, 2017
PKAN is an autosomal recessive disorder with mutations in the PANK2 gene, encoding an essen- tial enzyme for CoA biosynthesis. The molecular connection between defects in this enzyme and the neurodegenerative phenotype observed in PKAN patients is still ...
ZIZIOLI, DANIELA   +5 more
core  

Home - About - Disclaimer - Privacy